Overcoming Real-World Barriers to TED Treatment
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Kimberly Cockerham, MD
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Applying CAS, EUGOGO, VISA: A Micro Case
Why Staging TED Correctly Matters Even When CAS Is Low
Why QoL Measures Change TED Management
Designing Efficient Clinic Workflows for TED Therapy Access
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Andrew G. Lee, MD
Valerie Biousse, MD
KOL KNOCKOUTTM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
Andrew R. Harrison, MD
Kian Eftekhari, MD
Wendy W. Lee, MD
Nicholas Robert Mahoney, MD
Amina Malik, MD
Jeremiah Tao, MD, FACS
Hiding in Plain Sight: A Multidisciplinary Effort to Improve Identification and Treatment of Thyroid Eye Disease
Andrea Kossler, MD, FACS
Jennifer Murdock, MD
Eve Bloomgarden, MD
Loading...
We're glad to see you're enjoying Evolve Medical Education… but how about a more personalized experience?
Press cancel to remain on Evolve Medical Education. Press the link below or the continue button to keep going.